Trade Mark Journal No.2021/053 31 December 2021
WO0000001631353 (5)
Office of origin: European Union Intellectual Property Office (EUIPO)
Date of International Registration:3 November 2021
Date of designation in the UK:
3 November 2021

International priority date claimed: 2 July 2021
(European Union Intellectual Property Office (EUIPO))
(018505510)
- Class 5
- Pharmaceuticals and medical preparations for human use; pharmaceutical preparations within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for pulmonary fibrosis namely ipf; pharmaceutical preparations for diffuse systemic sclerosis (lung manifestations); pharmaceutical preparations for infectious lung diseases; pharmaceutical preparations for covid-19.
Vicore Pharma AB
Representative: POTTER CLARKSON AB, Convendum Regeringsgatan 48, SE-111 56 Stockholm, SWEDEN